Breaking News on Global Pharmaceutical Technology & Manufacturing

La Belle Paris... CPhI 2014

CPhI Worldwide Paris 2014

CPhI Worldwide 2014 was held on our home turf, albeit four hours by train, in Paris. Despite transport problems the event was, as usual, crowded and hectic. We scoured the floors to bring you the best the Villepinte Conference Centre had to offer.


The key to market exclusivity? Forget molecules, patent your tests

21-Oct-2014 - Makers of branded drugs are finding ways to extend their marketing authorisation by patenting not only molecules, but patient screening methods and ways of proving bioequivalence.

News from CPHI Paris

Doctors ask for quick-dissolve meds to stop in-patient cheating

21-Oct-2014 - Patients receiving court-ordered treatment can be stopped from secretly spitting out their medicines by formulations which dissolve quickly in the mouth.


A bitter pill to swallow: young people dislike tablets more than old

20-Oct-2014 - Changing pills to a more user-friendly formulation can increase patient compliance, brand loyalty, and extend IP exclusivity, says CMO Hermes in an exclusive podcast.

news from cphi

CDMO strategic deals 'the new standard,' say Catalent and DPx, but big and small pharma demands differ

16-Oct-2014 - Strategic relationships with contract manufacturers are becoming the standard, but big and small pharma demands differ considerably according to the two largest CDMOs, DPx and Catalent.

News from cphi

Big Pharmas and API suppliers eyeing Brazilian Government deals says EMS

16-Oct-2014 - Government contracts guaranteeing market share in Brazil are starting to attract innovators like Roche, Novartis and Sanofi and may see API suppliers get long-term work according to a spokesman for...

Exclusive interview

Global regulators demanding needless drug quality levels, says Indian Gov

15-Oct-2014 - Overzealous and unnecessary quality demands by some regulatory agencies are driving up the cost of medicines, according to the Indian Government.

News from CPhI

DSM cuts out China's ATS-8 intermediate middlemen with enzyme-made statin APIs

14-Oct-2014 - Royal DSM has launched a statin API it claims is made using a green production method that reduces reliance on intermediate suppliers.

Exclusive interview

CDMOs: Leave aseptic manufacturing to the Vetters of this world, says Aesica

14-Oct-2014 - Aesica has turned its back on sterile injectables manufacturing and, in an exclusive interview, told there is now limited steriles capability in the UK following the exit of other...

News from CPhI

Halal: accessing the untapped $30bn pharma market

13-Oct-2014 - The pharmaceutical industry must change its ingredients and manufacturing methods to cash in on the enormous purchasing power of European Muslims, says an expert.

Sabic: Compatible plastics to cut costs and up safety in single-use bioreactors

10-Oct-2014 - Biomanufacturing costs and the risk of extractables and leachables can be reduced by developing more compatible plastics, Sabic told at CPhI in Paris.

Drug Industry in Paris for CPhI

08-Oct-2014 -   [View the story "Pharma industry goes to Paris" on Storify]

Share API audits or see quality slump, says Hovione

08-Oct-2014 - The sharing of audit reports for active pharmaceutical ingredients (APIs) is essential in order to help avert the global decline in quality, according to Hovione’s CEO.

Pre CPhI Special

Complex regs and unknown markets top API shippers' logistics headaches

02-Oct-2014 - The world is getting larger, at least it is in terms of the pharmaceutical industry, according to execs who cite security concerns when shipping to new markets as the top...

Pre CPhI Special

How green was my Valium? Not very, despite industry claims

01-Oct-2014 - Making active pharmaceutical ingredients (API) is a dirty business and you’d have to be pretty green to believe claims drug industry 'demand' will create a $100bn market for environmentally-friendly production...

Key Industry Events


Access all events listing

Our events, Shows & Conferences...